This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pharmacokinetic interactions with rifampicin: Clinical relevance.Clin Pharmacokinet. 2003; 42: 819-850
- The effect of rifampin treatment on intestinal expression of human MRP transporters.Am J Pathol. 2000; 157: 1575-1580
- Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone.J Clin Pharmacol. 2008; 48: 66-72
- Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.Clin Pharmacol Ther. 2000; : 592-597
- Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.Clin Pharmacol Ther. 2005; 78: 154-167
- Clinical pharmacokinetics of fluvastatin.Clin Pharmacokinet. 2001; 40: 263-281
- Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.Br J Clin Pharmacol. 2004; 57: 181-187
- Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity.Mol Pharmacol. 2008; 74: 309-311
- Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.Pharm Res. 2006; 23: 506-512
- Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study.Clin Ther. 2008; 30: 1283-1289
- Bosentan is a substrate of human OATP1B1 and OATP1B3: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.Drug Metab Dispos. 2007; 35: 1400-1407
- Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.Clin Pharmacol Ther. 2007; 81: 194-204
- Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.Clin Pharmacol Ther. 2006; 80: 477-485
- Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.Clin Ther. 2003; 25: 2822-2835
Article info
Identification
Copyright
© 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc.
